TM, G., & JP, B. (2025). More than just another IDH inhibitor: Insights from the HMPL-306 phase 1 trial. Med (New York, N.Y.), 6(6), 100600. https://doi.org/10.1016/j.medj.2025.100600
Chicago Style (17th ed.) CitationTM, Getz, and Bewersdorf JP. "More than Just Another IDH Inhibitor: Insights from the HMPL-306 Phase 1 Trial." Med (New York, N.Y.) 6, no. 6 (2025): 100600. https://doi.org/10.1016/j.medj.2025.100600.
MLA (9th ed.) CitationTM, Getz, and Bewersdorf JP. "More than Just Another IDH Inhibitor: Insights from the HMPL-306 Phase 1 Trial." Med (New York, N.Y.), vol. 6, no. 6, 2025, p. 100600, https://doi.org/10.1016/j.medj.2025.100600.
Warning: These citations may not always be 100% accurate.